M-M-R II: cost and payments to doctors
What Medicare Part D paid pharmacies for M-M-R II, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Part D cost for M-M-R II formulations
Medicare reports M-M-R II under its specific formulations, which are priced separately.
- m m r ii vaccine$102per 30-day fill · 15,732 claims · Measles,mumps,rubella Vacc/Pf
Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?
Was your doctor paid by Merck?
Merck reported the most payments naming M-M-R II. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $692K
- Providers
- 19,285
- Transactions
- 32,781
- Average per transaction
- $21
The per-transaction average — $21 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 19,285 providers the average total is $36, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $691,734 | 100.0% |
Other products from Merck
The company that reported the most payments naming M-M-R II also reports against these.